BioSpace News Archive

Business

Medical Device Innovation Consortium Announces CEO William V. Murray is Stepping Down to Return to Private Sector; Board Begins Search for New Leader

The Medical Device Innovation Consortium (MDIC) CEO William V. (Bill) Murray today announced he will step down as President & CEO effective February 2, 2018 to return to the private sector.

November 9, 2017
·
2 min read
Business

REGENXBIO Reports Third Quarter 2017 Financial Results and Recent Operational Highlights

Cash, cash equivalents and marketable securities were $191.1 million as of September 30, 2017, compared to $159.0 million as of December 31, 2016.

November 9, 2017
·
12 min read
Business

Athersys Reports Third Quarter 2017 Results

Management to host conference call at 4:30 pm EST today.

November 9, 2017
·
10 min read
Business

FibroGen Reports Third Quarter 2017 Financial Results

FibroGen will host a conference call and webcast today, November 8, 2017, at 5:00 p.m. ET to discuss financial results and provide a business update.

November 9, 2017
·
11 min read
Business

Adverum Biotechnologies Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Cash, cash equivalents and marketable securities were $186.6 million as of September 30, 2017, compared to $197.4 million as of June 30, 2017 and $222.2 million as of December 31, 2016.

November 9, 2017
·
9 min read
Business

iCAD Reports Third Quarter 2017 Financial Results

Total revenue of $7.0 million, up 17% year-over-year.

November 9, 2017
·
25 min read
Business

Cascadian Therapeutics Reports Third Quarter 2017 Financial Results

Cash, cash equivalents and investments totaled $113.0 million as of September 30, 2017, compared to $62.8 million at December 31, 2016.

November 9, 2017
·
9 min read
Business

Achaogen Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Conference call today at 4:30 p.m. Eastern Time.

November 9, 2017
·
10 min read
Business

Collegium Reports Third Quarter Financial Results and Provides Corporate Update - Nov. 9, 2017

Net product revenues for Xtampza ER for the 2017 Quarter were $12.0 million ($7.6 million without the one-time $4.4 million increase) compared to $408,000 for the quarter ended September 30, 2016 (the “2016 Quarter”).

November 9, 2017
·
14 min read
Business

Rockwell Medical Reports Third Quarter Results

Sales were $14.6 million, an increase of 14.1% or $1.8 million over third quarter of 2016.

November 9, 2017
·
9 min read